Stay updated with breaking news from Access Pool. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
GENEVA: Spain’s top research institution reached a licensing deal Tuesday that paves the way for its Covid-19 antibody test to be produced more cheaply in developing countries. The World Health Organization (WHO) described the accord as the first transparent, global, non-exclusive license for a Covid-19 health tool that will help correct “devastating global inequity.” The deal
GENEVA (Reuters) - A global licence for serological technology that detects COVID-19 antibodies will be provided royalty-free to poor and middle-incom...
A global licence for serological technology that detects COVID-19 antibodies will be provided royalty-free to poor and low-income countries
WHO’s COVID-19 Technology Access Pool (C-TAP) and the Medicines Patent Pool (MPP) today finalized a licensing agreement with the Spanish National
The existing four tests, which check for the presence of SARS-CoV-2 antibodies developed after either an infection or a vaccine dose, could also inform decisions on the need for boosters to protect against the disease.